Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (965)
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
9,135
Price
$26.93
Total Value
$246.01K
Shares Held After
1,640,616
% of Holdings
0.6%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
4,308
% of Holdings
46.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
100
Price
$130.33
Total Value
$13.03K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
639
Price
$129.17
Total Value
$82.54K
Shares Held After
100
% of Holdings
86.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
561
Price
$128.23
Total Value
$71.94K
Shares Held After
739
% of Holdings
43.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,500
Price
$127.13
Total Value
$190.69K
Shares Held After
1,300
% of Holdings
53.6%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,502
Price
$125.96
Total Value
$189.20K
Shares Held After
2,800
% of Holdings
34.9%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
2,044
Price
$26.84
Total Value
$54.86K
Shares Held After
401,946
% of Holdings
0.5%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$23.01
Total Value
$103.53K
Shares Held After
196,141
% of Holdings
2.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
8,000
Price
$23.01
Total Value
$184.06K
Shares Held After
200,641
% of Holdings
3.8%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
4,693
% of Holdings
33.7%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
12,107
% of Holdings
12.8%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
4,725
% of Holdings
29.0%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
5,492
% of Holdings
33.6%
Whitehawk Therapeutics, Inc. (WHWK)
Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Shares
77,000
Price
$3.86
Total Value
$297.22K
Shares Held After
436,824
% of Holdings
15.0%
Processa Pharmaceuticals, Inc. (PCSA)
Bigora Sian — Chief Development Officer
Shares
1,799
Price
$2.97
Total Value
$5.34K
Shares Held After
5,510
% of Holdings
32.6%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$11.70
Total Value
$11.70K
Shares Held After
8,450
% of Holdings
11.8%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.14
Total Value
$1.00M
Shares Held After
1,466,934
% of Holdings
1.7%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
43,375
Price
$40.14
Total Value
$1.74M
Shares Held After
353,356
% of Holdings
10.9%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
86,971
Price
$40.14
Total Value
$3.49M
Shares Held After
396,731
% of Holdings
18.0%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
9,044
Price
$40.14
Total Value
$363.03K
Shares Held After
396,731
% of Holdings
2.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$96.90
Total Value
$193.80K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.61
Total Value
$278.47K
Shares Held After
412,498
% of Holdings
4.4%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
235,863
Price
$44.64
Total Value
$10.53M
Shares Held After
3,247,025
% of Holdings
6.8%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
235,863
Price
$44.64
Total Value
$10.53M
Shares Held After
3,247,025
% of Holdings
6.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
385
Price
$90.10
Total Value
$34.69K
Shares Held After
674,956
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,750
Price
$90.10
Total Value
$247.77K
Shares Held After
3,899,917
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,200
Price
$89.95
Total Value
$197.89K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,300
Price
$90.00
Total Value
$117.00K
Shares Held After
61,202
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
4
Price
$171.19
Total Value
$684.76
Shares Held After
15,666
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
8
Price
$170.76
Total Value
$1.37K
Shares Held After
15,670
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
68
Price
$169.15
Total Value
$11.50K
Shares Held After
15,678
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
537
Price
$168.64
Total Value
$90.56K
Shares Held After
15,746
% of Holdings
3.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
383
Price
$167.58
Total Value
$64.18K
Shares Held After
16,283
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
327
Price
$584.24
Total Value
$191.05K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
202
Price
$583.41
Total Value
$117.85K
Shares Held After
40,840
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,624
Price
$582.05
Total Value
$945.25K
Shares Held After
41,042
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,819
Price
$581.05
Total Value
$1.64M
Shares Held After
42,666
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,255
Price
$580.02
Total Value
$1.31M
Shares Held After
45,485
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
684
Price
$579.14
Total Value
$396.13K
Shares Held After
47,740
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
629
Price
$577.81
Total Value
$363.44K
Shares Held After
48,424
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$576.98
Total Value
$507.74K
Shares Held After
49,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$575.29
Total Value
$46.02K
Shares Held After
49,933
% of Holdings
0.2%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
92,554
Price
$0.76
Total Value
$70.34K
Shares Held After
197,052
% of Holdings
47.0%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
1,018
Price
$42.61
Total Value
$43.38K
Shares Held After
111,473
% of Holdings
0.9%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
1,014
Price
$42.61
Total Value
$43.21K
Shares Held After
116,899
% of Holdings
0.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.66
Total Value
$175.59K
Shares Held After
69,792
% of Holdings
8.3%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
1,559
Price
$42.53
Total Value
$66.30K
Shares Held After
105,211
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
5,226
Price
$41.62
Total Value
$217.51K
Shares Held After
106,770
% of Holdings
4.7%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
20
Price
$42.66
Total Value
$853.20
Shares Held After
432,886
% of Holdings
0.0%
Showing 351–400 of 965 transactions (page 8 of 20)